HOME › DRUGS › MIPOMERSEN SODIUM
ACTIVE SUBSTANCE / INN

MIPOMERSEN SODIUM

Brand name(s): Kynamro, KYNAMRO
FDA LISTED
EMA LISTED
DISCONTINUED
REFUSED
Hypercholesterolemia
NDA203568
ACTIVE SUBSTANCE
Mipomersen Sodium
REGULATORS
FDA · EMA
SPONSORS / MAH
KASTLE THERAPS LLC, Genzyme Europe BV
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KYNAMRONDA203568KASTLE THERAPS LLCDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KynamroGenzyme Europe BVRefusedHypercholesterolemia

FULL INTELLIGENCE ON MIPOMERSEN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →